Cellebrite DI (CLBT) Gains from Investment Securities (2020 - 2025)
Cellebrite DI's Gains from Investment Securities history spans 6 years, with the latest figure at -$239000.0 for Q4 2025.
- Quarterly Gains from Investment Securities fell 106.29% to -$239000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.2 million through Dec 2025, down 68.15% year-over-year, with the annual reading at $11.2 million for FY2025, 193.45% up from the prior year.
- Gains from Investment Securities came in at -$239000.0 for Q4 2025, down from $287000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $22.6 million in Q1 2024 to a low of -$1.8 million in Q3 2024.
- The 5-year median for Gains from Investment Securities is $840500.0 (2023), against an average of $3.4 million.
- The largest YoY upside for Gains from Investment Securities was 4666.85% in 2024 against a maximum downside of 303.43% in 2024.
- Cellebrite DI's Gains from Investment Securities stood at $1.4 million in 2021, then surged by 157.03% to $3.7 million in 2022, then crashed by 125.38% to -$946000.0 in 2023, then soared by 501.8% to $3.8 million in 2024, then plummeted by 106.29% to -$239000.0 in 2025.
- Per Business Quant, the three most recent readings for CLBT's Gains from Investment Securities are -$239000.0 (Q4 2025), $287000.0 (Q3 2025), and $12.3 million (Q2 2025).